Company: DVAX
Filing Date: 2025-01-13
Form Type: 8-K
Source: 0001029142-25-000003
Chunk: 0

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-01-13
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On January 13, 2025, Dynavax Technologies Corporation ("Dynavax" or the "Company") issued a press release announcing its preliminary unaudited fourth quarter and full year 2024 financial highlights. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K, and is incorporated herein by reference.

The preliminary selected financial results included in the press release are based upon estimates and information available as of the date of the press release. Accordingly, undue reliance should not be placed on these preliminary estimates. In addition, the Company has not yet completed its financial close process for the quarter and year ended December 31, 2024, therefore the estimates included in the press release regarding net product revenue and cash and cash equivalents, and marketable securities are preliminary, unaudited and are subject to change upon completion of the Company’s financial statement closing procedures and the audit of the Company’s consolidated financial statements.

Item 7.01 Regulation FD Disclosure.